121 related articles for article (PubMed ID: 7639418)
21. Effects of a moderate-intensity aerobic program on blood viscosity, platelet aggregation and fibrinolytic balance in young and middle-aged sedentary subjects.
Coppola L; Grassia A; Coppola A; Tondi G; Peluso G; Mordente S; Gombos G
Blood Coagul Fibrinolysis; 2004 Jan; 15(1):31-7. PubMed ID: 15166941
[TBL] [Abstract][Full Text] [Related]
22. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
Stegnar M; Mavri A
Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
[TBL] [Abstract][Full Text] [Related]
24. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
[TBL] [Abstract][Full Text] [Related]
25. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
[TBL] [Abstract][Full Text] [Related]
26. [Tissue and urokinase plasminogen activators (t-PA, u-PA) and their inhibitor PAI-1 in blood of patients with laryngeal neoplasms].
Białkowska A; Kotschy M; Betlejewski S; Burduk D
Otolaryngol Pol; 1995; 49 Suppl 20():84-7. PubMed ID: 9454229
[TBL] [Abstract][Full Text] [Related]
27. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
Legnani C; Frascaro M; Guazzaloca G; Ludovici S; Cesarano G; Coccheri S
Arzneimittelforschung; 1993 Feb; 43(2):119-22. PubMed ID: 8457236
[TBL] [Abstract][Full Text] [Related]
28. Effect of blood passage through the pulmonary circulation on fibrinolytic parameters.
Kloboves-Prevodnik V; Sabovic M; Keber D
Heart Vessels; 2004 Jan; 19(1):33-7. PubMed ID: 14685753
[TBL] [Abstract][Full Text] [Related]
29. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
30. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
31. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
Mehta P; Parker RI
J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
[TBL] [Abstract][Full Text] [Related]
32. Fibrinolytic activity in laparoscopic cholecystectomy.
Martinez-Ramos C; Lopez-Pastor A; Núñez-Peña JR; Ruiz-Caravaca ML; Ruiz de Gopegui M; Sanz-López R; Jorgensen TW; Tamames-Escobar S
J Laparoendosc Adv Surg Tech A; 1998 Dec; 8(6):417-23. PubMed ID: 9916595
[TBL] [Abstract][Full Text] [Related]
33. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
[TBL] [Abstract][Full Text] [Related]
34. Fibrinolytic responses to acute physical activity in older hypertensive men.
DeSouza CA; Dengel DR; Rogers MA; Cox K; Macko RF
J Appl Physiol (1985); 1997 Jun; 82(6):1765-70. PubMed ID: 9173939
[TBL] [Abstract][Full Text] [Related]
35. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
36. Impaired fibrinolytic activity induced by ingestion of butter: effect of increased plasma lipids on the fibrinolytic activity.
Kozima Y; Urano T; Serizawa K; Takada Y; Takada A
Thromb Res; 1993 Apr; 70(2):191-202. PubMed ID: 8322287
[TBL] [Abstract][Full Text] [Related]
37. [Effect of yimai jiangya extract on platelet activation and fibrinolytic activity and angiotensin II in aged patients with essential hypertension].
Duan X; Yang D; Sun X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jul; 20(7):508-10. PubMed ID: 11789207
[TBL] [Abstract][Full Text] [Related]
38. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
39. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
[TBL] [Abstract][Full Text] [Related]
40. Platelet function and fibrinolytic activity following distance running.
Knudsen JB; Brodthagen U; Gormsen J; Jordal R; Nørregaard-Hansen K; Paulev PE
Scand J Haematol; 1982 Nov; 29(5):425-30. PubMed ID: 7156892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
